Key Highlights

  • Hain Celestial shares rose 9.62% to USD 0.1470 in pre-market trading on November 3, 2026.
  • The company said on November 2, 2026 it will report fiscal 2027 first quarter results on November 9, 2026.
  • Nasdaq granted a second compliance period through March 22, 2027 for the minimum bid price rule.
  • Total Debt was USD 558 million at June 30, 2026, down from USD 705 million.
  • Fiscal 2026 net sales were USD 1,353 million, down 13%.

What Moved Hain Celestial Stock in Pre-Market Trading (up USD 0.0129, 9.62%)?

The Hain Celestial Group (NASDAQ:HAIN) rose 9.62% to USD 0.1470 in pre-market trading on November 3, 2026, against the Monday, November 2 close. The screen price is used as given.

No announcement tied directly to the move was identified. On November 2, 2026, the company issued a notice that it will report fiscal 2027 first quarter results before the market opens on Monday, November 9, 2026, with a call at 8:00 AM ET. The gain looks more like pre-earnings positioning in a very low-priced stock than a response to new information.

Hain's Listing Situation

In a regulatory filing dated September 28, 2026, Hain said Nasdaq notified it on March 24, 2026 that its stock had closed below USD 1.00 for 30 consecutive Business days. Nasdaq granted a second compliance period through March 22, 2027, and the stock moved to the Nasdaq Capital Market on September 24, 2026.

To regain compliance, the stock must close at or above USD 1.00 for at least 10 consecutive business days. The company said it intends to act, including a Reverse Stock Split if necessary, and cannot assure compliance.

Company Profile and Latest Results

Hain, based in Hoboken, New Jersey, describes itself as a global health and wellness company with brands including Celestial Seasonings, The Greek Gods and Earth's Best Organic.

According to its results release dated September 14, 2026, fourth quarter net sales were USD 263 million, down 28%, with a net loss of USD 62 million. Full-year net sales were USD 1,353 million, down 13%, with a net loss of USD 305 million including impairments. Adjusted EBITDA for the year was USD 89 million.

The company also agreed to divest its International business to Aurelius Investment Advisory Limited for an estimated USD 323 million in cash.

Balance Sheet and Penny Stock Risks

Total debt was USD 558 million and cash USD 58.1 million at June 30, 2026, with net secured Leverage of 4.5 times. Management has said a lender extension of the December debt Maturity is still being pursued. Stocks trading below USD 1 carry heavy volatility, thin Liquidity and dilution risk, and pre-market trading magnifies each.

What Should Investors Watch Next?

The November 9, 2026 results and call are the next catalysts, including updates on the International sale, the debt maturity extension and any reverse split plan. Price action around the Nasdaq USD 1.00 threshold will also matter.